PHAT (PHAT) Stock Price & Analysis
PHAT (PHAT) rose 4.97% to USD 9.5 as of September 8, 2026 at 05:47 UTC, according to Nexqual real-time market data.
PHAT last closed at USD 9.5; the session ranged USD 8.89–9.55 on volume of 1,236,691 shares. Market capitalization is —, with a 52-week range of USD 8.21–18.31 (NMS). Source: Nexqual, September 8, 2026 at 05:47 UTC.
Key Statistics (as of September 8, 2026 at 05:47 UTC)
| Price | USD 9.5 |
|---|---|
| Change | ▲ 4.97% (up) |
| Previous Close | USD 9.5 |
| Open | USD 9.5 |
| Day Range | USD 8.89 – 9.55 |
| 52-Week Range | USD 8.21 – 18.31 |
| Volume | 1,236,691 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PHAT)
Nexqual's technical model rates PHAT "SELL" based on 2 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 05:47 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.59 (neutral) |
| vs SMA50 | Below (USD 10.05) |
| MACD | -0.15 (negative) |
From PHAT's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.86 | ▼ 2.06% |
| MIRM | Mirum Pharmaceuticals, Inc. | USD 100.9 | ▲ 1.07% |
| TARS | Tarsus Pharmaceuticals, Inc. | USD 90.78 | ▲ 9.69% |
| KROS | Keros Therapeutics, Inc. | USD 11.32 | ▲ 0.8% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:47 UTC. This page is informational and not investment advice.